BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11161854)

  • 1. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models.
    Mol BW; Boll D; De Kanter M; Heintz AP; Sijmons EA; Oei SG; Bal H; Brölmann HA
    Gynecol Oncol; 2001 Feb; 80(2):162-7. PubMed ID: 11161854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of mathematical models to distinguish between benign and malignant adnexal tumors: a multicenter study by the International Ovarian Tumor Analysis Group.
    Van Holsbeke C; Van Calster B; Valentin L; Testa AC; Ferrazzi E; Dimou I; Lu C; Moerman P; Van Huffel S; Vergote I; Timmerman D;
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4440-7. PubMed ID: 17671128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.
    Timmerman D; Testa AC; Bourne T; Ferrazzi E; Ameye L; Konstantinovic ML; Van Calster B; Collins WP; Vergote I; Van Huffel S; Valentin L;
    J Clin Oncol; 2005 Dec; 23(34):8794-801. PubMed ID: 16314639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of diagnostic models to estimate the risk of malignancy in adnexal masses.
    Van Holsbeke C; Van Calster B; Bourne T; Ajossa S; Testa AC; Guerriero S; Fruscio R; Lissoni AA; Czekierdowski A; Savelli L; Van Huffel S; Valentin L; Timmerman D
    Clin Cancer Res; 2012 Feb; 18(3):815-25. PubMed ID: 22114135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors.
    Timmerman D; Van Calster B; Jurkovic D; Valentin L; Testa AC; Bernard JP; Van Holsbeke C; Van Huffel S; Vergote I; Bourne T
    J Clin Oncol; 2007 Sep; 25(27):4194-200. PubMed ID: 17698805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Mol et al. Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models. Gynecol Oncol 2001;80:162-7.
    Timmerman D; Verrelst H; Collins WP; Bourne TH; Vergote I
    Gynecol Oncol; 2001 Oct; 83(1):166-8. PubMed ID: 11585433
    [No Abstract]   [Full Text] [Related]  

  • 7. Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses.
    Timmerman D; Verrelst H; Bourne TH; De Moor B; Collins WP; Vergote I; Vandewalle J
    Ultrasound Obstet Gynecol; 1999 Jan; 13(1):17-25. PubMed ID: 10201082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adnexal masses management: a prospective multicentric observational study].
    Huchon C; Bats AS; Bensaïd C; Junger M; Nos C; Chatellier G; Lécuru F
    Gynecol Obstet Fertil; 2008 Nov; 36(11):1084-90. PubMed ID: 18964176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilocular adnexal cysts with papillary projections but no other solid components: is there a diagnostic method that can classify them reliably as benign or malignant before surgery?
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2013 May; 41(5):570-81. PubMed ID: 22915541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of a new logistic model in the preoperative evaluation of adnexal masses.
    Alcázar JL; Errasti T; Laparte C; Jurado M; López-García G
    J Ultrasound Med; 2001 Aug; 20(8):841-8. PubMed ID: 11503920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative diagnosis of ovarian tumors using Bayesian kernel-based methods.
    Van Calster B; Timmerman D; Lu C; Suykens JA; Valentin L; Van Holsbeke C; Amant F; Vergote I; Van Huffel S
    Ultrasound Obstet Gynecol; 2007 May; 29(5):496-504. PubMed ID: 17444557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved risk of malignancy index in diagnosis of adnexal mass.
    Wang LM; Song H; Song X; Zhou XB
    Chin Med J (Engl); 2012 Feb; 125(3):533-5. PubMed ID: 22490416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing benign and malignant pelvic masses: the value of different diagnostic methods in everyday clinical practice.
    Engelen MJ; Bongaerts AH; Sluiter WJ; de Haan HH; Bogchelman DH; Tenvergert EM; Willemse PH; van der Zee AG
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):94-101. PubMed ID: 17118522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of malignancy of adnexal lesions using ADC entropy: comparison with mean ADC and qualitative DWI assessment.
    Kierans AS; Bennett GL; Mussi TC; Babb JS; Rusinek H; Melamed J; Rosenkrantz AB
    J Magn Reson Imaging; 2013 Jan; 37(1):164-71. PubMed ID: 23188749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis and predictors of malignancy of adnexal masses.
    Murta EF; Nomelini RS
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):14-9. PubMed ID: 16493254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology.
    Petri AL; Simonsen AH; Yip TT; Hogdall E; Fung ET; Lundvall L; Hogdall C
    Acta Obstet Gynecol Scand; 2009; 88(1):18-26. PubMed ID: 19023702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of size of the adnexal mass on the accuracy of frozen section diagnosis.
    Geomini PM; Zuurendonk LD; Bremer GL; de Graaff J; Kruitwagen RF; Mol BW
    Gynecol Oncol; 2005 Nov; 99(2):362-6. PubMed ID: 16051343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of adnexal masses using feature analysis at contrast-enhanced helical computed tomography.
    Zhang J; Mironov S; Hricak H; Ishill NM; Moskowitz CS; Soslow RA; Chi DS
    J Comput Assist Tomogr; 2008; 32(4):533-40. PubMed ID: 18664838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests.
    Daemen A; Valentin L; Fruscio R; Van Holsbeke C; Melis GB; Guerriero S; Czekierdowski A; Jurkovic D; Ombelet W; Rossi A; Vergote I; Bourne T; De Moor B; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Jan; 37(1):100-6. PubMed ID: 20814878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group.
    Timmerman D; Van Calster B; Testa AC; Guerriero S; Fischerova D; Lissoni AA; Van Holsbeke C; Fruscio R; Czekierdowski A; Jurkovic D; Savelli L; Vergote I; Bourne T; Van Huffel S; Valentin L
    Ultrasound Obstet Gynecol; 2010 Aug; 36(2):226-34. PubMed ID: 20455203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.